David L Brautigan

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Preterm Infants

Intellectual Disability

Tyrosine Kinase

Top Venues

Radiology. Imaging cancer

Clinical science (London, England : 1979)

This page only lists publications with an associated author ORCID identifier.

Publications

Ana Limerick, Ellie A McCabe, Jacob S Turner, Kevin W Kuang, David L Brautigan, Yi Hao, Cheuk Ying Chu, Sean H Fu, Sean Ahmadi, Wenhao Xu, Zheng Fu
An Epilepsy-Associated CILK1 Variant Compromises KATNIP Regulation and Impairs Primary Cilia and Hedgehog Signaling. Cells 13 (15) (2024)
Ana Limerick, Ellie A McCabe, Jacob S Turner, Kevin W Kuang, David L Brautigan, Yi Hao, Cheuk Ying Chu, Sean H Fu, Sean Ahmadi, Wenhao Xu, Zheng Fu
An Epilepsy-Associated CILK1 Variant Compromises KATNIP Regulation and Impairs Primary Cilia and Hedgehog Signaling. Cells 13 (15) (2024)
Ana Limerick, Ellie A McCabe, Jacob S Turner, Kevin W Kuang, David L Brautigan, Yi Hao, Cheuk Ying Chu, Sean H Fu, Sean Ahmadi, Wenhao Xu, Zheng Fu
An Epilepsy-Associated CILK1 Variant Compromises KATNIP Regulation and Impairs Primary Cilia and Hedgehog Signaling. Cells 13 (15) (2024)
Vishnu M Chandra, Luke R Wilkins, David L Brautigan
Animal Models of Hepatocellular Carcinoma for Local-Regional Intraarterial Therapies. Radiology. Imaging cancer 4 (4) (2022)
David L Brautigan
Phosphorylase phosphatase and flash activation of skeletal muscle glycogen phosphorylase-A tribute to Edmond H. Fischer. IUBMB life (2022)
Elena X Wang, Jacob S Turner, David L Brautigan, Zheng Fu
Modulation of Primary Cilia by Alvocidib Inhibition of CILK1. International journal of molecular sciences 23 (15) (2022)
David L Brautigan, Caroline Farrington, Goutham Narla
Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents. Clinical science (London, England : 1979) 135 (13) (2021)